Utilizing Endotypes, Phenotypes, and Inflammatory Markers to Guide Treatment Decisions in Chronic Rhinosinusitis
With the advent of new treatment options for Chronic Rhinosinusitis (CRS) comes the ability for physicians to provide more individualized patient care. Physicians are now tasked with identifying who may be the best candidate for a particular therapy. In this review, existing biomarkers and potentially new methods that could guide treatment choices in CRS patients will be discussed.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Anna G. Staudacher, Anju T. Peters, Atsushi Kato, Whitney W. Stevens Tags: CME Reviews Source Type: research